Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page
- CheckyesterdayChange DetectedA sitewide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check8 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check15 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe history now shows a new Revision: v3.7.0 entry, replacing the previous Revision: v3.6.6. This indicates an updated version of the page history captured for the study record.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, replacing the previous v3.6.5 entry. This reflects an update to the record's revision history rather than changes to the study data.SummaryDifference0.1%

- Check78 days agoChange DetectedThe study record history now shows a new revision entry v3.6.5, indicating the page was updated to that revision.SummaryDifference0.1%

Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.